| Financial Year |
March 31 2023 |
| Monetary Funds |
13,109,700,618.69 |
| Held-for-trading Financial Assets |
107,293,498.63 |
| Notes Receivable |
-- |
| Accounts Receivable |
4,638,355,295.54 |
| Advances to Suppliers |
709,520,382.39 |
| Other Receivables |
885,080,393.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,634,300,120.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,006,897,762.37 |
| Total Current Assets |
27,952,215,509.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
184,249,433.56 |
| Long-term Equity Investment |
5,267,344,500.26 |
| Investment Properties |
60,687,319.64 |
| Fixed Assetes |
11,469,907,211.24 |
| Under-construction Projects |
1,016,202,231.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,063,620,064.24 |
| R&D expenses |
586,331,970.10 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,340,010.36 |
| Deferred Income Tax Assets |
1,075,143,763.19 |
| Other Non-Current Assets |
27,229,387.41 |
| Sub-Total of Non-Current Assets |
21,866,566,266.19 |
| Total Assets |
49,818,781,775.94 |
| Short-Term Loans |
596,275,430.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,918,478,681.47 |
| Accounts Payable |
11,492,436,238.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
450,055,724.63 |
| Taxes Payable |
162,088,747.13 |
| Interest Payable |
-- |
| Dividend Payable |
1,652.82 |
| Other payables |
2,816,806,244.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,621,692,655.39 |
| Other Current Liabilities |
448,166,388.34 |
| Sub-Total of Current Liabilities |
28,985,427,268.19 |
| Long-term Loans |
5,357,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
45,887.85 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,054,424.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,645,621,641.27 |
| Total Liabilities |
35,631,048,909.46 |
| Paid-In Capital(Or Share Stock) |
2,184,009,791.00 |
| Capital Surplus |
6,923,313,915.55 |
| Surplus Reserve |
1,672,973,383.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,813,621,255.55 |
| Minority Stockholder's Interest |
410,157,141.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,777,575,724.88 |
| Owner's Equity（Stockholder's Equity） |
14,187,732,866.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
49,818,781,775.94 |
